克拉斯
生殖细胞肿瘤
生物
病理
畸胎瘤
神经母细胞瘤RAS病毒癌基因同源物
免疫组织化学
表型
癌症研究
医学
突变
遗传学
基因
化疗
作者
Sabrina Rossi,Sabina Barresi,Alessandra Stracuzzi,Oscar Lopez‐Nunez,Stefano Chiaravalli,Andrea Ferrari,Andrea Ciolfi,Giuseppe Maria Milano,Isabella Giovannoni,Marco Tartaglia,Evelina Miele,Rita Alaggio
标识
DOI:10.1016/j.prp.2021.153553
摘要
DICER1 syndrome is characterized by a unique combination of features and a growing list of associated rare tumors. Traditionally, gonadal or extra-gonadal teratomas have not been considered part of this spectrum, with only rare DICER1-related teratoid neoplasms recently reported. Besides, their methylation profiles remain elusive. We report two DICER1-associated malignancies involving the lumbar spine of a 22-year-old man (case 1) and the pelvic cavity of a 14-year-old girl (case 2). Both tumors exhibited teratoma-like features with a high-grade malignant somatic component, including rhabdomyosarcomatous elements for case 1 and a malignant neuroectodermal neoplasm with features of an embryonal tumor with multilayered rosettes (ETMR) for case 2. Both tumors showed strong SALL4 expression and H3K27me3 loss by immunohistochemistry. Next-generation sequencing studies confirmed biallelic DICER1 mutations with additional pathogenic missense mutations in KRAS (case 1) and CTNNB1 (case 2). The methylation profile of case 1 clustered with DICER1-associated sarcomas, whereas case 2 classified as an ETMR (albeit low raw and calibrated score). In conclusion, we report two DICER1-related malignancies with teratoma-like features, further expanding their morphologic spectrum and highlighting the multipotentiality of their presumed cell of origin. Notably, we describe the first ETMR identified outside the CNS with a documented DICER1 biallelic inactivation. Our findings also highlight the potential role of other molecular alterations such as KRAS and CTNNB1 mutations in defining the phenotype of embryonal and primitive DICER1-associated neoplasms, a notion that deserves further studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI